Spondyloarthritis
Overview of axial and peripheral spondyloarthritis.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)
Last reviewed: 21 October 2025
regional clinical guidance
Spondyloarthritis: guidance by region
Recommendations, thresholds and pathways can differ. Open the page written for the jurisdiction you need.
United StatesEstablished axial spondyloarthritis: treatmentMusculoskeletal Β· reviewed 2026-08-20CanadaSpondyloarthritis: diagnosis and managementMusculoskeletal Β· reviewed 2026-08-20AustraliaSpondyloarthritis: recognition, referral and management: source-status boundaryMusculoskeletal Β· reviewed 2026-08-20
Clinical Guidelines
CKS: Axial spondyloarthritis (including ankylosing spondylitis)
National
CKS: Spondyloarthritis and psoriatic arthropathyNational
NICE guideline [NG65]National
NICE guideline [NG65]: Spondyloarthritis in over 16s: diagnosis and managementNational
2010 Update of the international ASAS recommendations for the use of anti-tumour necrosis factor agents in patients with axial spondyloarthritisLocal
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisLocal
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 updateLocal
Axial Spondyloarthritis Clinical Practice Guidelines (American College of Rheumatology)Local
Classification Criteria and Clinical Practice Guidelines for SpondyloarthritisLocal
NICE guideline [NG65]: Spondyloarthritis in over 16s: diagnosis and managementLocal